Department of Surgery, Vievis Namuh Hospital, Seoul, South Korea.
J Gastrointest Surg. 2010 Aug;14(8):1331-7. doi: 10.1007/s11605-010-1165-3. Epub 2010 Feb 9.
The distal resection margin (DRM) has been considered an important factor for the oncological outcome of rectal cancer surgery. However, the optimal distal margins required to achieve safe oncological outcome remains to be controversial.
More recently, as circumferential resection margin or mesorectal margin has been additionally reported to be more important factors predicting patient outcome than the distal mucosal margin, a re-evaluation of the impact of DRM on patient outcome is needed.
The extent of distal tumor spread is known to be influenced by a variety of factors such as tumor location, lymph node metastasis, and tumor size. DRM might affect survival more than a local recurrence. Because distal intramural tumor spread rarely exceeds 1 to 2 cm in most rectal cancers, and local control and survival do not seem to be compromised by shorter distal resection margins, the generally accepted practice is to aim for a 2-cm DRM. However, in the recent trend of curative resection after preoperative chemoradiotherapy, with an otherwise favorable tumor such as well-differentiated tumor and no lymph node metastasis, a DRM at < or =1 cm does not necessarily portend a poor prognosis. In cases with preoperative chemoradiotherapy, distal resection margins need to be evaluated individually.
It has been suggested that down-staging of low-lying rectal cancers after preoperative radiation might well include the pathological clearance of distal intramural microscopic spread. Moreover, the measurement of DRM varies with respective study, making it difficult to compare.
We need an applicable intraoperative method to accurately measure distal resection margin, enabling comparative outcome.
远端切缘(DRM)被认为是直肠癌手术肿瘤学结果的一个重要因素。然而,实现安全肿瘤学结果所需的最佳远端切缘仍存在争议。
最近,由于环周切缘或中直肠切缘被报道为比远端黏膜切缘更能预测患者预后的因素,因此需要重新评估 DRM 对患者预后的影响。
远端肿瘤扩散的程度已知受到多种因素的影响,如肿瘤位置、淋巴结转移和肿瘤大小。DRM 对生存的影响可能大于局部复发。由于大多数直肠癌的远端壁内肿瘤扩散很少超过 1 至 2cm,并且较短的远端切除边缘似乎不会影响局部控制和生存,因此通常的做法是争取 2cm 的 DRM。然而,在术前放化疗后的根治性切除的最近趋势中,对于分化良好的肿瘤且无淋巴结转移等有利的肿瘤,<或=1cm 的 DRM 不一定预示预后不良。对于术前放化疗的病例,需要单独评估远端切除边缘。
有人认为术前放疗后低位直肠癌的降期可能包括远端壁内微观扩散的病理性清除。此外,DRM 的测量因各自的研究而异,难以比较。
我们需要一种适用的术中方法来准确测量远端切除边缘,从而实现可比较的结果。